This preprint examined how immune reconstitution, as represented by CD4+ T-cell recovery, and prior antigenic exposure history relate to virus-specific humoral immunity in people with HIV. The cohort comprised individuals receiving antiretroviral therapy (ART) who were virologically suppressed and were sampled across distinct CD4+ T-cell strata. The investigators characterized neutralizing antibody activity against three pathogen groups: SARS-CoV-2, HIV-1, and influenza. The abstract reports comparative patterns across CD4 groups and across viral variants or strains.
Across the CD4+ T-cell strata studied, neutralizing activity against SARS-CoV-2 revealed a consistent dominant target: the BA.5 lineage. In contrast, neutralization of the ancestral D614G variant showed a positive association with the degree of immune reconstitution, increasing with higher CD4+ T-cell counts. This indicates that recovery of CD4+ T cells is associated with stronger neutralizing responses to some SARS-CoV-2 antigens but not uniformly across all variants.
The CD4-associated gradient observed for D614G neutralization was largely absent when neutralizing activity was measured against antigenically divergent, immune-evasive SARS-CoV-2 variants, specifically NB.1.8.1 and XFG. In other words, improved CD4+ T-cell counts correlated with better neutralization of certain earlier or less antigenically drifted virus forms (D614G), but that association did not hold for variants that have evolved greater antigenic divergence and immune evasion. This finding highlights how viral antigenic evolution can decouple conventional immune metrics from functional humoral protection.
Neutralizing responses against HIV-1 displayed an inverse relationship with CD4+ T-cell count in the cohort described: higher HIV-1 neutralization was associated with lower CD4+ levels. The abstract does not provide mechanistic explanations or detailed numeric data; it reports this inverse association as an observed pattern across the sampled population. This result suggests that the dynamics of antibody responses to HIV-1 in people on ART may differ fundamentally from those for other viral pathogens and may reflect historical exposure, ongoing B-cell imprinting, or other immune phenomena.
For influenza, neutralization patterns were strain-dependent. The abstract indicates heterogeneity of influenza-specific humoral responses across strains but does not supply detailed comparisons or quantitative results. This strain dependence reinforces that relationships between CD4+ T-cell recovery and functional antibody responses can vary by pathogen and by antigenic specificity within a pathogen group.
The investigators applied neutralization-to-protection bridging to infer how measured neutralizing titers might translate into protective immunity. Using this bridging approach, they observed that the CD4-associated gradient persisted for the D614G SARS-CoV-2 variant—meaning inferred protection tracked with CD4 recovery for that variant—but the gradient did not hold for highly immune-evasive variants. This suggests that translating laboratory neutralization results into estimates of clinical protection may be valid for some antigenic contexts but not for others when viral evolution reduces the predictive value of standard neutralization assays.
The study concludes that immune reconstitution, as measured by CD4+ T-cell recovery, does not uniformly restore or predict antiviral humoral function across pathogens and viral variants. Instead, antibody profiles in ART-treated, virologically suppressed people with HIV appear to reflect an interplay of host immune status, prior antigenic exposure history, and the antigenic evolution of viruses. The authors propose that pathogen-specific functional assessment of antibodies (for example, variant- or strain-specific neutralization assays) should complement conventional immune monitoring based on CD4+ T-cell counts. Such combined evaluation may better capture clinically relevant antiviral humoral function in this population.
Note on article status
This report is a preprint and has not been peer reviewed. The abstract provides summary findings but does not include full methodological details or quantitative data; those elements would be found in the full manuscript and supplementary materials referenced by the preprint.